Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations.
about
LRP-1: a checkpoint for the extracellular matrix proteolysisC766T low-density lipoprotein receptor-related protein 1 (LRP1) gene polymorphism and susceptibility to breast cancerThe Matricellular Receptor LRP1 Forms an Interface for Signaling and Endocytosis in Modulation of the Extracellular Tumor EnvironmentMatrix-bound PAI-1 supports cell blebbing via RhoA/ROCK1 signalingPAI-1 expression is required for epithelial cell migration in two distinct phases of in vitro wound repairDual role for plasminogen activator inhibitor type 1 as soluble and as matricellular regulator of epithelial alveolar cell wound healingPlasminogen activator inhibitor-1 regulates myoendothelial junction formation.Selective loss of TGFbeta Smad-dependent signalling prevents cell cycle arrest and promotes invasion in oesophageal adenocarcinoma cell linesBreast cancer and metabolic syndrome linked through the plasminogen activator inhibitor-1 cycleADAM12 and alpha9beta1 integrin are instrumental in human myogenic cell differentiation.Blueberry phytochemicals inhibit growth and metastatic potential of MDA-MB-231 breast cancer cells through modulation of the phosphatidylinositol 3-kinase pathway.LRP-1 promotes cancer cell invasion by supporting ERK and inhibiting JNK signaling pathwaysThe aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesis.Low density lipoprotein (LDL) receptor-related protein 1B impairs urokinase receptor regeneration on the cell surface and inhibits cell migration.Variation in innate immunity genes and risk of multiple myelomaSERPINE1 (PAI-1) is a prominent member of the early G0 --> G1 transition "wound repair" transcriptome in p53 mutant human keratinocytes.SERPINE1 (PAI-1) is deposited into keratinocyte migration "trails" and required for optimal monolayer wound repairObesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1Old dogs and new tricks: proteases, inhibitors, and cell migration.Plasminogen activator inhibitor 1 (PAI-1): in vitro activities and clinical relevance.LRP-1--CD44, a new cell surface complex regulating tumor cell adhesion.Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth.LRP-1 silencing prevents malignant cell invasion despite increased pericellular proteolytic activitiesAccumulation of uPA-PAI-1 complexes inside the tumour cells is associated with axillary nodal invasion in progesterone-receptor-positive early breast cancerProgesterone receptor isoforms PRA and PRB differentially contribute to breast cancer cell migration through interaction with focal adhesion kinase complexesPAI-1 and functional blockade of SNAI1 in breast cancer cell migration.Role of hypoxia and HIF2α in development of the sympathoadrenal cell lineage and chromaffin cell tumors with distinct catecholamine phenotypic features.LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studiesProteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancyCharacteristics of the level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1.Effects of specific chemical suppressors of plasminogen activator inhibitor-1 in cardiovascular diseases.Plasminogen activator inhibitor-1 inhibitors: a patent review (2006-present).The PAI-1 gene as a direct target of endothelial PAS domain protein-1 in adenocarcinoma A549 cells.Activated thrombin-activatable fibrinolysis inhibitor attenuates the angiogenic potential of endothelial cells: potential relevance to the breast tumour microenvironment.Low-density lipoprotein receptor-related protein 1 promotes cancer cell migration and invasion by inducing the expression of matrix metalloproteinases 2 and 9.PAI-1 transcriptional regulation during the G0 --> G1 transition in human epidermal keratinocytes.Upstream stimulatory factor regulates E box-dependent PAI-1 transcription in human epidermal keratinocytes.Essential role of the low density lipoprotein receptor-related protein in vascular smooth muscle cell migration.Plasminogen activator inhibitor 1 protects fibrosarcoma cells from etoposide-induced apoptosis through activation of the PI3K/Akt cell survival pathway.Repression of Ah receptor and induction of transforming growth factor-beta genes in DEN-induced mouse liver tumors.
P2860
Q21285122-F3CF4F7B-9FFC-470D-AE8C-509A78C0C174Q24803584-F0E14341-4A8A-4EA0-98CF-86361B59B2A5Q26776179-68A1D276-FA2E-46F4-9E68-78A74BB07035Q27308674-BE6D8A3D-3B9A-4226-90E5-9E5EF89DC472Q28576370-261AF847-97D4-4CEB-A22E-77DB385CC54DQ28580473-CE9D3BB9-76BA-4CD4-AFAB-55B4AED78F1FQ30436548-5F035431-6A3A-4B05-87CC-20520B300A4EQ33271014-4FB721A4-888F-4AB2-8660-DF076776F616Q33715393-09C72C95-6557-4AEE-BB56-9E5408A5314DQ33763885-14A1F24F-CD0C-48DE-8262-F468BD81472CQ33820727-1AD3A78D-02E1-4263-AD9F-6556369F841AQ33996198-B00757F9-282B-4F99-9630-7898AE8C6A12Q34128053-0B715045-191B-4D0C-A88E-99F01401435AQ34145983-03AC38FA-B039-42E1-AB58-581B620860C7Q34306330-5E1D1E4E-C28F-4D38-809C-9E84C94A3430Q34691253-0D9F3EA9-81EA-4008-B2C0-5DB8344F1A57Q34767246-C761432D-27B1-4D17-9925-3677ABB83B4CQ34996841-32374F40-166D-4775-BFBC-665807C677E9Q35167706-1FD8E27D-C26A-449D-A65E-14F3BC41EB45Q35688843-AEC1B109-7028-4EF5-8C5D-2A1E1FA1F68AQ36211012-1E876678-3D26-46B3-B5FE-387B7EABCD26Q36324730-E05A8074-A6AC-458D-A472-B30958DC6610Q36540227-CC91DFF8-DCE4-4FA8-AC7B-27100CCC0832Q36647801-F7B73A50-0E99-4B35-BF56-79D705D2BCA5Q36803178-1334DA9A-2DAD-430E-A087-DB18B80DF4A2Q37131335-B103FE12-4786-4133-A1CF-D6ABC7B27D68Q37202015-598247B9-7BF2-4B5B-B5FF-967E42F87597Q37216064-F2A55D94-9D9B-4032-8F70-23CEC6C42775Q37465475-613DEA28-0936-44C8-B535-BDDD1D1FF9FBQ37801943-2486A783-B775-4CD3-81A6-6820AB0C1AEDQ37824876-72894AF5-9261-4B19-B9D4-C608CBCBD5C7Q38092174-6D015D03-E1C6-4319-B450-2D6A7E214B84Q38343290-E875BEC6-43C4-49A2-B269-F81FF2962146Q38719374-B55CACA9-DAD8-4B56-BCC4-BEE0C1FEA0E4Q39889999-38776966-C194-4ADB-A37E-1E2D817325A6Q40290480-91ADECB0-0888-4789-8CE1-683A14C703DFQ40515008-DE9C3E26-924F-431E-AA21-CB4267A3AFDFQ40611910-6E960421-F387-47D7-9AA7-7BBA28DC1D4EQ42136467-7EE2C3FC-004E-4C02-81BB-867DC3AC9428Q43151984-BD2C7D75-14C4-499C-A39B-C8D676212546
P2860
Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Promigratory effect of plasmin ...... reast cancer cell populations.
@ast
Promigratory effect of plasmin ...... reast cancer cell populations.
@en
type
label
Promigratory effect of plasmin ...... reast cancer cell populations.
@ast
Promigratory effect of plasmin ...... reast cancer cell populations.
@en
prefLabel
Promigratory effect of plasmin ...... reast cancer cell populations.
@ast
Promigratory effect of plasmin ...... reast cancer cell populations.
@en
P2093
P2860
P1476
Promigratory effect of plasmin ...... breast cancer cell populations
@en
P2093
Anne Plonquet
Christo Christov
Georgia Barlovatz-Meimon
Romain K Gherardi
Rémy Ricoux
P2860
P304
P356
10.1016/S0002-9440(10)64367-2
P407
P577
2002-01-01T00:00:00Z